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Influence of dendritic polyglycerol sulfates
on knee osteoarthritis: an experimental
study in the rat osteoarthritis model
Tobias Schneider1,4, Pia Welker2, Kai Licha2, Rainer Haag3 and Gundula Schulze-Tanzil1,4*
Abstract
Background: Anti-inflammatory nanoparticular compounds could represent a strategy to diminish osteoarthritis
(OA) progression.
The present study was undertaken to prove the uptake of nanoparticular dendritic polyglycerol sulfates (dPGS) by
rat-derived articular chondrocytes and to answer the question of whether dPGS could modulate knee joint cartilage
degradation in a rat OA model and whether complications could arise.
Methods: dPGS uptake and cytotoxicity was assessed in cultured primary rat-derived articular chondrocytes.
Subsequently, OA was induced in the right knee joints of 12 male Wistar rats by medial collateral ligament and
meniscus transection. Unoperated left knees remained as controls. Six weeks post surgery six rats were either
treated daily (14 days) with 30 mg/kg dPGS (s.c.) or a similar volume of physiological saline. Animals were analyzed
clinically for gait alterations. Explanted knee joints were studied histologically using OA scores according to Mankin
(1971), Glasson et al., (2010) and the synovitis score according to Krenn et al., (2006). Liver, spleen and kidneys were
analyzed for degenerative changes due to dPGS accumulation.
Results: dPGS was taken up after 2 hours by the chondrocytes. Whereas no significant clinical signs of OA could be
detected, at the histological level, all operated rat knee joints revealed features of OA in the medial compartment.
The values produced by both OA score systems were lower in rats treated with dPGS compared with saline-treated
animals. Synovitis score did not significantly differ between the groups. The analyzed organs revealed no
degenerative changes.
Conclusions: dPGS presented overall cyto- and biocompatibility, no accumulation in metabolizing organs and
chondroprotective properties in the osteoarthritic knee joint.
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Background
OA development and progression is associated with in-
flammatory events affecting chondrocytes and synovial
fibroblasts. Osteoarthritis (OA) is highly prevalent in
Western society today, with more than two third of people
over 65 years old with osteoarthritic alterations in their
joints [1]. Besides age, other risk factors associated with OA
such as obesity, traumatic cartilage injury, genetics, and
muscle weakness are well known [2]. Pro-inflammatory
cytokines such as tumor necrosis factor alpha (TNFα) or
interleukin 1 (IL-1) are elevated in synovial fluids of OA pa-
tients [3]. The increased production of catabolic enzymes,
mediated by pro-inflammatory cytokines, and impaired
extracellular matrix de novo synthesis facilitates destruction
of cartilage extracellular matrix, over time. Therefore, ex-
perimental strategies should be explored, which might be
able to shift that imbalance back in a more favorable state.
Nanoparticular compounds have not only been studied as
potential drug delivery systems [4] but also have been
proven to be therapeutically effective [5, 6]. Dendritic
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polyglycerols can be coupled with sulfate ions by substitut-
ing prior attached hydroxyl groups leading to dendritic
polyglycerol sulfates (dPGS) which possess anti-
inflammatory abilities, for example they reduce the migra-
tion of white blood cells.
In a previous in vitro study dPGS showed no cytotox-
icity on chondrocytes and penetrated to some degree
(50 μm) through the cartilage extracellular matrix [7]. It
could upregulate anti-inflammatory IL-10 and modulate
pro-inflammatory TNFα expression [7].
In the present work rat-derived articular chondrocytes
were characterized and treated with dPGS in vitro to
study its uptake. Further, OA was surgically induced in
the right knees of adult Wistar rats before treated with
dPGS to answer the following questions. 1. Do cultured
rat-derived articular chondrocytes take dPGS up? 2. Are
dPGS biocompatible? 3. Does dPGS modulate knee joint
inflammation and cartilage degradation in a rat OA
model? 4. Does dPGS accumulate during a treatment for
two weeks and does it lead to complications in vivo? For
answering the second question histological OA scoring
served as an endpoint. To study putative side effects of
dPGS accumulation main metabolic, excretory and im-
mune organs were analyzed histopathologically.
Methods
Isolation and culturing of rat chondrocytes
Three adult male Wistar rats (Charles River Laboratories,
Germany) were euthanized and cartilage slices were
shaved from the articular surface of both knee joints. All
the procedures with the rats were approved by the local
animal ethics committee of Berlin, Germany (registration
number G0159/11 and T0224/08). Afterwards, pooled
cartilage slices were incubated in 1.5 mL pronase (2 %
[Serva Electrophoresis GmbH, Germany]) solution for
20 minutes at 37 °C. The remaining pure cartilage was
rinsed 2× with phosphate buffered saline (PBS). Subse-
quently 1.5 mL of collagenase solution was added and the
sample was incubated again at 37 °C until the extracellular
matrix was completely digested. Thereafter, cells were
counted and seeded for future experiments in T-25 cell
culture flasks (Sarstedt AG, Germany).
Immunofluorescence labelling of cultured primary
articular chondrocytes
The chondrocytes were cultured on cover slips for
48 hours before fixed using 4 % paraformaldehyde solu-
tion (PFA [Santa Cruz Biotechnology, Inc., USA]). The
cells were treated with blocking solution consisting of
5 % donkey serum in Tris-buffered Saline (TBS) and
0.1 % Triton (Sigma Aldrich, Germany). Subsequently,
the chondrocytes were incubated with the polyclonal
rabbit-anti-human type II collagen, type I collagen anti-
bodies (both 1:60, Acris Antibodies, Germany), Sox9
antibody (Chemicon, USA) or monoclonal mouse-anti-
human vinculin antibody (Sigma Aldrich) overnight at
4 °C. Thereafter the cover slips seeded with chondro-
cytes were washed with TBS and incubated with the
secondary antibody (donkey-anti-rabbit or donkey-
anti-mouse IgG) coupled with Alexa-488 (1:200, Life
Technologies, USA) or Cy3 (Invitrogen, USA) and 4’,
6-diamidino-2-phenylindole dihydrochloride (1:200,
DAPI [Roche Applied Science, Germany]) for 1 hour at
room temperature (RT).
Uptake and cellular localization of dPGS nanoparticular
compounds
The articular chondrocytes of the three rats (passage 3)
were cultured on poly-L-lysine coated cover slips (VWR
International, Germany) for 24 hours. Subsequently, cells
were stimulated for 2 hours to 7 days with dPGS at a
concentration of 10−6 mol/L which was linked with ICC
(Indocarbocyanine, mivenion GmbH, Germany). At each
point in time the cells were fixed using 4 % PFA and
then stained with DAPI (Sigma Aldrich) to visualize the
cell-nuclei and phalloidin-FITC (Sigma Aldrich) to de-
pict the actin cytoskeleton. Images were taken using the
fluorescence microscope Axioskop 40 (Zeiss AG,
Germany) equipped with an Olympus XC30 camera
(Olympus Soft Imaging solutions GmbH, Germany).
FACS (fluorescence activated cell sorting) analysis of
uptake and release of dPGS in rat chondrocytes
The pool of rat articular chondrocytes was seeded at a
density of 20.000 cells/cm2 in T-25 cell culture flasks
(passage 4). After 24 hours the cells were either treated
with dPGS-ICC or as a control with glycerol-ICC (both
groups: 10−6 mol/L, mivenion GmbH, Germany, for
2 hours, 72 hours and 7 days). One flask remained un-
treated as control. Then, trypsinized cells were fixed
with 4 % PFA and resuspended in FACS buffer. 10.000
events per sample have been counted using a FACSCalibur
machine (Becton, Dickinson and Company, USA) and data
was analyzed using the FlowJo Software (version 7.6, Tree
Star, Inc., USA).
OA induction in the rat model
To assess the effects of dPGS on injured cartilage and
joint tissue in vivo OA was surgically induced in the
knee joints of 12 adult male Wistar rats (Charles River
Laboratories, Germany). The right knees of the rats were
surgically destabilized by medial collateral ligament and
meniscus transection while the left knees remained un-
treated as a control group [8, 9]. Before and for two days
after surgery the animals received Rimadyl s.c. (5 mg/kg
body weight, Pfizer Inc., USA) as analgetic. The rats
were subsequently anesthetized using a combination of
ketamine (80 mg/kg body weight, WDT, Germany),
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acepromazine (1 mg/kg body weight, Ceva Sante Animale,
France) and xylazine (5 mg/kg body weight, Bayer AG,
Germany) i.p.. Afterwards, selecting a medial approach the
transection of the medial ligamentum collaterale and
partial resection of the medial meniscus was performed
(Fig. 1 a1-a3). For the following 8 weeks the animals under-
went a forced mobilization procedure on a self-constructed
rotor disc apparatus (Fig. 1b). After 6 weeks the animals,
randomly divided into two groups by picking numbers out
of a hat, were either treated with 100 μL dPGS (30 mg/kg
body weight) or with saline (0.9 %, Fresenius Kabi GmbH,
Germany). Both was administered subcutaneously once a
day for 2 weeks. After 8 weeks the animals were sacrificed.
Furthermore, the animals were weighed each week over
the course of the whole experiment.
Footprinting analysis
At specific points in time (week 1, 5 and 7) a footprinting
analysis was done to measure the influence of OA and the
treatment on stride length and step width of the animals.
The rat’s hind paws were inked and the animals were
encouraged to walk over a white paper walking track.
Decalcification and paraffin embedding of rat knee joints
and organs
The explanted joints were fixed using 4 % PFA solu-
tion for three days and decalcified in formic acid (5 %,
Carl Roth, Germany). Then they were incubated with
ammonia solution (Merck KGaA, Germany) for 30 mi-
nutes to ensure neutralization and afterwards rinsed
in water for 24 h. After rinsing in water, the samples
were dehydrated using an ascending ethanol series and
embedded in paraffin. To assess a possible accumula-
tion of dPGS in organs responsible for drug elimin-
ation liver, spleen and kidneys were explanted.
Histological staining and scoring
Deparaffinized sections (3–5 μm) were Haematoxylin Eosin
(HE) stained using a standard protocol. For Alcian Blue
(AB) staining, the sections were incubated for 3 minutes in
1 % acetic acid and then stained 15 minutes in 1 % AB
(Carl Roth GmbH). Subsequently, they were rinsed in 3 %
acetic acid and cell nuclei counterstained using nuclear fast
red aluminium sulfate solution (Carl Roth GmbH) for 5 mi-
nutes. For the safranin-O staining the slides were incubated
for 10 minutes in a Weigert’s iron hematoxylin (Carl Roth
GmbH) and afterwards rinsed in running tap water for
10 minutes. Subsequently, the sections were stained in
0.001 % fast green solution (Sigma-Aldrich) for 5 minutes.
After rinsing them briefly in 1 % acetic acid the slides were
stained in 0.1 % safranin-O solution (Merck KGaA) for up
to 5 minutes. Dehydrated sections were mounted with
Entellan mounting medium (Merck KGaA). The stained
sections were further analyzed by applying score systems by
Fig. 1 a-b OA induction in the Wistar rat model and forced mobilization apparatus. Twelve male Wistar rats underwent surgical destabilization
of the right knee joint in response to dissection of the ligamentum collaterale mediale and meniscus medialis leading to OA. a1: skin incision,
a2: ligamentum collaterale mediale, a3: joint space (arrow). To ensure OA development the rats started one week after surgery a daily training
using a forced rotor disc mobilization device (b)
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two observers. To consider species-dependent peculiarities
in rats two scoring systems for OA were used, the well-
established Mankin Score, which was originally designed
for human cartilage and the score system adapted by Glas-
son et al., [10] suitable for the very thin rodent joint car-
tilage. The scoring system according to Krenn et al.,
[11] was applied to classify synovitis.
Statistical analysis
Data were expressed as mean values with standard de-
viation and analyzed using one sample t test, one-way
ANOVA with a post-hoc Tukey Test (GraphPad Prism 5,
GraphPad software Inc, USA) and the Mann Whitney U
Test. The GRUBB’s test was performed to identify outliers.
If applicable, the Kolmogorov-Smirnov test was used to
prove the presence of a Gaussian distribution. Statistical
significance was set at a p value of ≤ 0.05.
Results
Characterization of primary adult rat articular
chondrocytes
During further culturing the rat articular chondrocytes
gained a more flattened and fibroblast-like appearance.
Nevertheless, they still expressed the typical cartilage
marker type II collagen and the master chondrogenic
transcription factor sox9 (Additional file 1: Figure S1).
Type I collagen which is an indicator of dedifferentiation
could also be detected (Additional file 1: Figure S1). The
immunolabelling for both collagen types was detected
extracellularly localized at extracellular matrix fibrils and
intracellularly in the perinuclear rER region. The ex-
pression of type II collagen and the nuclear signal for
sox9 did not decrease during the first passage. Compared
with the start of culture (passage 0) the visible F-actin
fiber bundles increased. A colocalization of vinculin
immunolabeling at the ends of F-actin fiber bundles indi-
cated focal adhesion sites (Additional file 1: Figure S1).
Uptake and localization of dPGS in rat articular
chondrocytes
The incubation of isolated articular chondrocytes of
rats with dPGS-ICC (c = 10−6 mol/L) led to a strong
fluorescent signal after 2 hours (Fig. 2a2) which in-
creased over the course of the next 72 hours (Fig. 2b2)
and even after 7 days (Fig. 2c2). Furthermore, a peri-
nuclear aggregation of dPGS-ICC was detected after
7 days. Controls, incubated with glycerol-ICC did not
exhibit any ICC-signal (Fig. 2a1, b1 and c1). The cyto-
skeletal actin was more intense stained in the un-
treated controls compared with the dPGS treated
samples (Fig. 2).
FACS based uptake and release study of dPGS-ICC by
rat-derived articular chondrocytes
All dPGS-ICC treated chondrocytes showed dPGS as-
sociated fluorescence (Fig. 2d). After 2 hours nearly
100 % of chondrocytes were positive for dPGS uptake
which could also be observed after 72 hours and 7 days.
Nevertheless, the mean fluorescence intensity (MFI)
after 72 hours nearly doubled in comparison with the
amount found after 2 hours or even 7 days. After 7 days
the MFI decreased to nearly the amount of the MFI
after 2 hours. Nevertheless, nearly 100 % of cells were
still positive for dPGS.
Histological staining of organs
Organs of the treated and untreated rats revealed no
macroscopical degenerative alterations. To assess a pos-
sible accumulation of nanoparticular dPGS and subse-
quent toxic changes in organs liver, spleen and kidneys of
treated and untreated rats were stained with HE and AB.
In dPGS treated rats the HE staining revealed no histo-
pathological alterations of liver, spleen and kidney
(Fig. 3a-b). In the dPGS treated group but also in the con-
trol animal group few cells in the connective tissue areas
of the liver which surround the vessels (the so-called Glis-
son trias) could be positively stained by AB suggesting the
presence of heparin containing mast cells. Additionally,
but only in the dPGS treated group some other cells were
AB positive (Fig. 3a1, b1). These dPGS containing cells
were mostly localized nearby the so-called space of Disse,
probably representing the phagocyting Kupffer cells. How-
ever, the hepatocytes were generally AB negative. Some
staining which was not cell-associated could also be de-
tected in the extracellular matrix of the faint connective
tissue layer surrounding the central veins (not shown).
The spleen revealed also several AB positive cells which
could only be detected in the dPGS treated animal group
(Fig. 3a2, b2). These cells, probably spleen macrophages
were localized in the red pulp whereas the white pulp of
the spleen was AB negative. The cortex of the kidney
was completely devoid of AB positivity (Fig. 3a3, b3).
The inner medulla revealed a slight staining in both
groups due to the extracellular content of sulfated gly-
cosaminoglycans there (not shown).
Changes in body weight, stride length and step width
between studies groups
The rats exposed no clinical signs of OA such as re-
duced activity, joint pain, −swelling or any visible gait
alterations. The body weight of animals, dPGS treated or
not, did not significantly change (Fig. 3c). The foot-
printing analysis revealed that, although the animals
had severe osteoarthritic changes in medial compart-
ments of their knees none of it led to a significant
change in stride length or step width (Fig. 4a-c).
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Histological staining of joint cartilage
At the macroscopical level no changes of the joint sur-
face or osteophyte formation could be detected. The rat
knee joints of the left legs which were not surgically
destabilized showed almost no signs of OA, neither in
the untreated (Fig. 5a1-a3) nor in dPGS treated rats
(Fig. 5b1-b3). The surfaces of the cartilage layer was al-
most completely smooth; no major fibrillation or other
degenerative features were detectable at all, an equal
chondrocyte distribution and an intact tidemark was de-
tected (Fig. 5a1-b3). Furthermore, the stainings of AB
and safranin-O were distributed within the zones as
expected for healthy rat articular cartilage. The joint car-
tilage of the right knees of the rats showed significantly
different results (Fig. 5a4-a6, b4-b6) than their left coun-
terparts. The tidemark was not any longer detectable
and the cartilage was severely disintegrated in the medial
joint compartiment (Fig. 5a4). Large areas of cartilage
completely devoid of cells could be found indicating
hypocellularity (Fig. 5a4-a6) and in some areas of the
chondrocytes formed clusters and even subchondral
cysts were found. In several cases cartilage fissures
extended deeply into the calcified zone of the joint car-
tilage. Furthermore, the safranin-O staining intensity
Fig. 2 a1-d Accumulation of nanoparticular compounds (dPGS) in cultured rat chondrocytes. Glass cover slides were seeded with rat articular
chondrocytes and incubated with respective glycerol-ICC (10−6 mol/L) as a control group (a1-c1) or dPGS-ICC (10−6 mol/L) (a2-c2). Representative
images were taken 2 hours (a1, a2), 72 hours (b1, b2), and 7 days (c1, c2) after stimulation. Depicted are phalloidin-Alexa488 (green) as cytoskeleton
staining, DAPI (blue) as the nucleus staining and ICC coupled dPGS (red) to visualize the accumulation and localization of dPGS (seeding density: 15.600
cells/cm2, cell passage: 4). Scale bar: 100 μm. d: Rat articular chondrocytes of three animals were pooled and incubated for 24 hours with dPGS-ICC or
respective glycerol-ICC as a control group (both: 10−6 mol/L). One control was left untreated to be used as an isotype control. The cells were evaluated
flow cytometrically. Depicted are the mean number of cells tested positive for dPGS uptake as percentage (data points) and the mean fluorescence
intensities of dPGS-ICC inside the cells (MFI [mean fluorescence intensity], bars) (events counted: 10.000, seeding density: 20.000 cells/cm2, cell derived
from 4th passage). A representative experiment is shown
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was severily reduced or a focally complete disintegra-
tion of cartilage extracellular matrix was discernible
(Fig. 5a6). In contrast to the untreated animals, rats
treated with dPGS revealed an overall less damaged car-
tilage (Fig. 5b4-b6). Damage of the cartilage structure
remained for most of the samples restricted to the car-
tilage surface. Only few cases with deeper joint cartilage
fissures were found. Accordingly, the proteoglycan
staining intensity and distribution in the joint cartilage
of the rats treated with the dPGS remained mostly as
usually expected under physiological conditions.
Osteoarthritis score analysis of treated and untreated rats
Evaluation of HE and safranin-O stained tissue sections
of treated and untreated rats was undertaken by applying
the Mankin score [12] and the scoring system proposed
by Glasson et al., [10] to them to monitor osteoarthritic
alterations. The left (not surgically destabilized) and the
right (surgically destabilized) knee joints of the rats were
highly significant different (p < 0.0001) when comparing
all animals of both groups (treated with dPGS or not).
The right knees showed a significantly higher score
proving the onset of OA than in the left knees underlined
Fig. 3 a-c Comparison of untreated rats and rats treated with dPGS concerning detectable dPGS deposition in the liver, spleen and kidney and
development of body weight in adult male Wistar rats over the course of 11 weeks. a-b: Paraffin sections of organs derived from male adult
Wistar rats were stained using AB. Depicted are the remaining dPGS nanoparticular compounds in the liver, spleen and kidney of the treated rats
(b1-3) in contrast to untreated rats (a1-3). Scale bars: 200 μm (a1-2, b1-2) and 100 μm (a3, b3). (a1) black arrow: mast cell, (a2) white arrow:
Kupffer cell, (b2) red arrow: spleen macrophage. c: Depicted are the control animals and the animals treated with dPGS (n = 12). The weight is
depicted as the percentage of weight in comparison to the weight at the beginning
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by the results of both scoring systems (Fig. 5c1-2). The
difference between the articular cartilage of the left knees
of rats treated with dPGS compared with those only re-
ceived saline injections was not significant. The compari-
son of the right knees of dPGS-treated and untreated
animals revealed that the Mankin and Glasson score of
treated animals was lower than the score of placebo
treated rats, suggesting their OA is less severe than the
ones of untreated rats (Fig. 5d1-2). Mankin and Glasson
scoring results of all animals revealed a significant
correlation (Fig. 6a). However, the difference did not
reach the significance level. Additionally, we scored
the synovial membrane of the joint capsule using the
score developed by Krenn et al. [11]. We found a sig-
nificant score difference between the left (control) and
right (OA) joint (Fig. 6b), while there was no difference
visible between the untreated and treated groups of left
joints (Fig. 6b) and neither between the right joints
(Fig. 6c).
Discussion
Due to the thin cartilage layer in rats the isolation of
adult rat articular chondrocytes derived from the knee
joint is challenging and only low cell numbers can be
harvested. Since it is well known that human and also
rat derived chondrocytes lose their specific differentiated
phenotype during cell expansion and further culturing in
monolayer a process called dedifferentiation [13–15], the
expression of cartilage markers was evaluated in the
present study. Cartilage-specific markers such as type II
collagen and sox9 could be demonstrated indicating that
the primary rat chondrocytes introduced in the experi-
ments exhibited still differentiated functions. Previous
studies indicated that chondrocytes can maintain their
differentiated phenotype for up to four passages in
monolayer culture [13, 14]. Cultured rat chondrocytes
easily took dPGS up as an important precondition for
using dPGS in the joint. In another study were viable
human cartilage chips were tested for penetration by
dPGS we found that dPGS could also penetrate the
cartilage extracellular matrix to some degree (50 μm
distance). The results of the FACS analysis suggest that
dPGS is not only taken up by the cells over the course
of the experiment but might also be actively segregated
again back in the culture supernatant. However, this
assumption requires further experimental support. An
instability OA model of the rat knee was selected in the
present study to test the effect of dPGS on OA progres-
sion. This OA model has already been used by various
research groups before [16–18]. Since OA needs several
weeks for manifestation in this model, the daily dPGS
treatment was started after 6 weeks and lasted for two
Fig. 4 a-c Comparison of stride length, step wide between treated and untreated rats and footprinting analysis. At defined points in time the
rats’ hind feet were inked and they were encouraged to walk over a white strip of paper. The stride length (a) and step width (b) of 12 adult
male Wistar rats (n = 6: treated; n = 6: untreated) was measured before surgical procedure (T1), 6 weeks after surgical treatment, before start of
treatment (T2) and before finalization, after two weeks of treatment (T3). A representative exemplary image of the measurement procedure is
shown. The image shows the gait pattern of an animal prior to surgery (c). le: left, ri: right leg
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Fig. 5 (See legend on next page.)
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weeks. The treatment had no effect on overall behavior,
body weight and gait of the rats indicating no clinical
signs of OA. To exclude toxic effects of the nanoparticu-
lar compounds during this rather long treatment course
we analyzed the histology of organs involved in metabolism
and elimination of toxic compounds such as liver, spleen
and kidney. The AB staining was used here to detect nega-
tively charged dPGS particles [19] and therefore, to moni-
tor a potential accumulation of dPGS within these organs.
It is known that administered nanoparticular compounds
can accumulate in secondary target organs [20, 21]. Some
cross reaction with heparin can usually be found using this
staining procedure due to its negative charges and similar
chemical composition like dPGS. Therefore, mast cells
which contain cytoplasmic heparin inclusions were also
stained positively blue with AB and could be detected in
the connective tissue of the liver surrounding the Glisson
trias vessels in all animals. In addition to these mast cells,
the dPGS treated animals but not the controls revealed
also dPGS positive Kupffer cells. This observation is sup-
ported by the study of Holzhausen, Gröger et al., [19].
Apart from this observation, the dPGS treatment did not
induce any histopathological changes in the investigated
organs suggesting that it might not impair organ function
at the administered dose and time course. In agreement,
some macrophages in the spleen revealed dPGS in the
dPGS treated rats, but not in the controls. However, dPGS
could not be shown in the kidneys. This observation sug-
gests that the parenchymal cells are able to eliminate the
dPGS in response to a daily treatment and a longer treat-
ment with dPGS could be possible. The onset of OA could
be proven in all animals included in this study, since there
was a highly significant difference in the Mankin Score and
also in the Glasson score values between the operated right
(See figure on previous page.)
Fig. 5 a-d Joint histology: comparison of untreated rats (a) and rats treated with dPGS (b) as well of histological scoring results (c, d). Representative
frontal cross sections of adult male Wistar rat joints are shown. Depicted is the joint space between femur condyle (top) and the tibia plateau (bottom).
Shown are the not surgical destabilized left knees of untreated (a1-3) and treated rats (b1-3). Furthermore, the surgical destabilized right knee of untreated
(a4-6) and those of dPGS treated animals (b4-6) are depicted. The tissue was stained using HE (a1, b1, a4, b4), AB (a2, b2, a5, b5) or safranin-O staining
(a3, b3, a6, b6). * =meniscus. The regions of interest are labeled by black arrows. Scale bar 200 μm. HE and safranin-O stained paraffin sections of rat knee
joints were evaluated using the score systems according to Mankin (1971) (c1, d1) and Glasson et al., (2010) (c2, d2). Depicted are the differences of the left
(not surgically altered) and the right knees (surgically destabilized) of all animals (n= 12) (c1-2). Furthermore, the differences between left knees and the
right knees for the untreated control and the treated animals are shown separately (d1-2). n= 6 per group. ***p< 0.001
Fig. 6 a-c Correlation between both OA scoring systems and assessment of the synovitis using the score according to Krenn et al., (2006). Correlation
between both scoring systems (a). Depicted are the differences of the left (not surgically altered) and the right knee (surgically destabilized) of all animals
(n= 12) (b). Furthermore, the differences between left and the right knees for the untreated control and the treated animals are shown
separately (c). n = 6 per group. **p < 0.01
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and unoperated left knee joints. The difference between
the right knee joints of the group treated with dPGS versus
the controls was clearly detectable and supported by histo-
pathology but it did not reach the significance level. There-
fore, it suggests that the dPGS treatment led to an
improvement in the condition of the knee joints of the
treated animals. Furthermore, the fact that the animals
treated with dPGS also showed a lower Mankin score value
than the untreated animals in their left knees, which were
not surgically destabilized underlines chondroprotective
capabilities of dPGS. The grade of synovitis was signifi-
cantly higher in operated compared to the unoperated legs
of the animals suggesting that OA progression was gener-
ally associated with synovitis in this rat model. Neverthe-
less, the differences between dPGS treated animals and
controls were not significant. However, neither clinical
signs of OA such as pain, joint swelling, warmness and
fluctuation nor macroscopical alterations could be found
during joint explantation. The mode of action of dPGS on
joint inflammation remains a matter of debate. Studies in
other inflammatory models revealed a suppressive effect of
dPGS on NF-κB and AP-1 activation. These both tran-
scription factors are involved in pathways leading to the
release of inflammatory cytokines [22, 23] and other medi-
ators or enzymes such as matrix-metalloproteinases [24].
Apart from its modulatory effect on IL-10 and TNFα [16],
dPGS affects also complement factors e.g. C5a and selec-
tins thereby impairing leukodiapedesis [5]. Several tissues
interact with each other under OA conditions [25]: apart
from articular cartilage, synovial membrane, infrapatellar
joint fat pad and subchondral bone cross-talk [26, 27].
Therefore, the mode of chondroprotective action of dPGS
requires further investigations.
This study has some limitations. Since we did not detect
clinical features of OA one should consider a more sensi-
tive testing system for gait analysis such as the so called
“cat walk” which is an automated quantitative gait analysis
system for rodents in the future. Furthermore, a sensitive
pain tests could be included. Since dPGS treatment led
generally to less severe histopathological OA in the rats,
more effective treatment profiles should be selected (earlier
start or longer duration of dPGS treatment) in the future.
Conclusions
The present study indicates a high cytocompatibility and
a rapid uptake of dPGS in cultured rat chondrocytes.
The Mankin and Glasson histological score values were
lower in OA rats treated with dPGS compared with
control animals. The analyzed organs revealed no de-
generative changes due to dPGS accumulation suggesting
biocompatibility. Taken together, the results indicate a
chondroprotective and anti-inflammatory potential of
dPGS in the osteoarthritic knee joint suitable to sup-
press OA progression.
Additional file
Additional file 1: Figure S1a1-e2. Characterization of cultured rat
primary knee joint chondrocytes. Primary chondrocytes immediately after
isolation (passage 0, upper row, a1-e1) and in the first passage (lower row,
a2-e2) are depicted light microscopically (a1-2) and were characterized for
the expression of type II collagen (green, b1-2), type I collagen (green, c1-2),
sox9 (green, d1-2) and vinculin (red)/F-actin (green) (e1-2). Cell nuclei are
counterstained using DAPI (blue). a1-2: scale bar 100 μm, b1-e2: scale bar
50 μm. (TIF 7376 kb)
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